Developing a new drug that blocks a key enzyme could stop breast cancer spreading to other parts of the body, according to a new UK study. Dr Janine Erler at the Institute of Cancer Research (ICR) in London, and colleagues, used lab models to show that blocking the enzyme lysyl oxidase-like 2 (LOXL2) reduced the spread of the cancer from the breast to the lungs, liver and bone...
More...
Linear Mode
